Part D Protected Class Debate Revives Questions On Rx Coverage Appeals
Executive Summary
MedPAC and members of Congress are suggesting that CMS should re-evaluate the Medicare Part D appeals procedures to ensure they adequately protects beneficiaries’ access to drugs.